The Recall Desk
ModerateFDA (Devices)·Z-0923-2021·Announced 2021-02-03

BD Stimex Insulated Needle Recall for Missing Contraindications

Becton Dickinson is recalling BD Stimex Insulated Needles because the instructions for use lack general contraindications.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is driven by a labeling omission (missing contraindications) rather than a physical defect or reported injury, fitting the rubric for minor labeling errors.

Plain-English summary

Becton Dickinson & Company is recalling BD Stimex Insulated Needles (22G x 2.13in, Catalog No. 404204) because the instructions for use (IFU) require an update to include general contraindications. The recall was initiated after the European Notified Body, NSAI, advised BD that the IFU needed this specific information.

The affected products are distributed in the United States and in Australia, Canada, Belgium, and Singapore. The recall covers all lots within the expiration date, identified by UDI (01)50382904042047. The agency has classified this as a Class II recall.

The recalled product

Product
BD Stimex Insulated Needle 22G x 2.13in ( 50 units/cs.) Indicated for administration of medications to affect anesthesia or analgesia to a specific anatomical location (region). Catalog No. 404204
Affected units
16,250

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All lots within expiration date UDI: (01)50382904042047

Distribution

Distributed in 18 states:

Part of a larger recall action

This product is one of 2 recalled by Becton Dickinson & Company under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 2 products in this recall →